Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis

Journal of Pediatrics

Volumn 135, Issue 1, 1999, Pages 111-114

  Debray, Dominique ^a,b,c   Maggiore, Giuseppe ^a,b,c   Girardet, Jean Philippe ^a,b,c   Mallet, Eric ^a,b,c   Bernard, Olivier ^a,b,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN A; PREDNISONE; PROTHROMBIN;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; REMISSION; SIDE EFFECT;

EID: 0033511303     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70339-2     Document Type: Article

References (21)

1. 1. Gregorio GV, Portmann B, Reid F, Donaldson PT, Doherty DG, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
2. 2. Maggiore G, Veber F, Bernard O, Hadchouel M, Homberg JC, Alvarez F, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993;17:376-81.
3. 3. Maggiore G, Bernard O, Homberg JC, Hadchouel M, Alvarez F, Hadchouel P, et al. Liver disease associated with anti-liver kidney microsome antibody in children. J Pediatr 1986;108: 399-404.
4. 4. Martini E, Abuaf N, Cavalli F, Durand V, Johanet C, Homberg JC. Antibody to liver cytosol (anti-LCl) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8: 1662-6.
5. 5. Maggiore G, Porta G, Bernard O, Hadchouel M, Alvarez F, Homberg JC, et al. Autoimmune hepatitis with initial presentation as acute hepatic failure in young children. J Pediatr 1990;116:280-2.
6. 6. Herzog D, Rasquin-Weber AM, Debray D, Alvarez F. Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation. J Hepatol 1997;27:578-82.
7. 7. Porta G, Gayotto LC, Alvarez F. Anti liver kidney microsome antibody positive autoimmune hepatitis presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr 1990;11:138-40.
8. 8. Maggiore G, Bernard O, Hadchouel M, Hadchouel P, Odièvre M, Alagille D. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr 1984;104:839-43.
9. 9. Czaja AJ, Beaver SJ, Shiels MT. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen negative chronic active hepatitis. Gastroenterology 1987;92:215-9.
10. 10. Mistilis SP, Vickers CR, Darroch MH, McCarthy SW. Cyclosporin, a new treatment for autoimmune chronic active hepatitis. Med J Aust 1985;143: 463-5.
11. 11. Hyams JS, Ballow M, Leichter AM. Cyclosporin treatment of autoimmune chronic active hepatitis. Gastroenterology 1987;93:890-3.
12. 12. Sherrnan KE, Narkewicz M, Pinto PC. Cyclosporin in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis. J Hepatol 1994;21:1040-7.
13. 13. Jackson LD, Song E. Cyclosporin in the treatment of corticosteroid-resistant autoimmune chronic active hepatitis. Gut 1995;36:459-61.
14. 14. Lie TS. Erfolgreiche Behandlung der chronisch-aktiven Hepatitis mit Cyclosporin-A. Munch Med Wschr 1984;126:693-4.
15. 15. Person JL, McHutchison JG, Fong TL, Redeker AG. A case of cyclosporin-sensitive, steroid-resistant autoimmune chronic active hepatitis. J Clin Gastroenterol 1993;17:317-20.
16. 16. Launay V, Gottrand F, Michaud L, Masy E, Turck D, Farriaux JP. Traitement par la cyclosporine d'une hépatite autoimmune révélée par une insuffisance hépatocellulaire aiguë. Arch Pediatr 1997;4:40-3.
17. 17. Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P, et al. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 1986;2:119-24.
18. 18. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18: 998-1005.
19. 19. Minuk GY. Cyclosporin A in non-transplant-related liver disease. Am J Gastroenterol 1989;84:1345-50.
20. 20. Morris PJ. Cyclosporin A. Transplantation 1981;32:349-54.
21. 21. Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989;9:198-203.